Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03437395 · ClinicalTrials.gov registry record · NA
Accelerated Partial Breast Irradiation Study
A NA study of Breast Cancer Female, sponsored by Sentara Norfolk General Hospital.
- Active
- Registry status
- NA
- Development phase
- 139
- Enrollment target
- 1
- Study location
NCT03437395 is a NA study of Breast Cancer Female that is active but no longer recruiting, run by Sentara Norfolk General Hospital. The registered enrollment target is 139 participants, below the 690-participant average among 46 other Breast Cancer Female trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03437395, a NA study of Breast Cancer Female, is active but no longer recruiting, sponsored by Sentara Norfolk General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 139 participants
- Enrollment target
- 1
- Study location
Study Summary
Breast cancer patients at Sentara RMH Hahn Cancer Center who are treated with accelerated partial breast irradiation will be monitored over a period of 10 years. From this group of patients, local and regional recurrence rates will be determined. Patients in the registry will also take part in assessments of cosmesis and quality of life.
Conditions Studied
Interventions
- DEVICE Balloon Brachytherapy
- RADIATION 3D Conformal External Beam Irradiation
Study Locations (1)
Virginia
- Sentara RMH Hahn Cancer Center - Harrisonburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2009-03-11 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03437395
The ClinicalTrials.gov registry entry for NCT03437395 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 690-participant average among 46 other Breast Cancer Female trials with a reported enrollment target (80% lower). The listed sponsor is Sentara Norfolk General Hospital, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer Female appearing as the primary indexed condition, and to 2 interventions - of which Balloon Brachytherapy is the first listed.
NCT03437395 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT03437395 about?
NCT03437395 is a clinical study titled "Accelerated Partial Breast Irradiation Study". Breast cancer patients at Sentara RMH Hahn Cancer Center who are treated with accelerated partial breast irradiation will be monitored over a period of 10 years. From this group of patients, local and regional recurrence rates will be determined. Patients in the registry will also take part in asses...
What is the current status of trial NCT03437395?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 139 participants. The study started on 2009-03-11. Estimated completion is 2025-12.
What conditions does trial NCT03437395 study?
This clinical trial studies the following conditions: Breast Cancer Female.
What interventions are being tested in trial NCT03437395?
The interventions under investigation include: Balloon Brachytherapy (DEVICE), 3D Conformal External Beam Irradiation (RADIATION).
Who is sponsoring clinical trial NCT03437395?
This trial is sponsored by Sentara Norfolk General Hospital, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03437395 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Female
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Breast Cancer Resiliency Through Exercise Program (B-REP)
RECRUITING · NA
-
Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women
RECRUITING · NA
-
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
RECRUITING · NA
-
Cognitive Rehabilitation Following Breast Cancer Treatment
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.